当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

In CKD Patients, Metabolic Acidosis is Linked to Acute Kidney Injury

Tan Navdeep gri

A loss of kidney function causes metabolic acidosis in patients with chronic kidney disease (CKD). It has been  linked to CKD progression, mortality from all causes, and other negative outcomes. Our goal was to see if metabolic acidosis is linked to an increased risk of acute kidney injury (AKI).

Chronic kidney disease (CKD) is a prevalent and serious health condition characterized by the progressive deterioration of renal function. It affects individuals of all age groups and is associated with significant morbidity and mortality rates. CKD develops as a result of various underlying etiologies, including diabetes, hypertension, glomerulonephritis,and genetic disorders. The pathophysiology involves a complex interplay of inflammation, oxidative stress, fibrosis,and impaired renal function. CKD is associated with a wide range of complications, such as cardiovascular disease,mineral and bone disorders, anemia, and electrolyte imbalances. Early detection and management of CKD are crucialto slow theprogression of the disease, delay the onset of complications, and improve outcomes. The management of CKD involves a multidisciplinary approach, including lifestyle modifications, pharmacological interventions, and renal replacement therapy in advanced stages. Renal transplantation is considered the gold standard treatment for ESRD, offering the best long-term outcomes and improved quality of life. However, access to transplantation is limited, and many patients rely on dialysis for survival. CKD imposes a substantial burden on healthcare systems, emphasizing the importance of preventive strategies, early detection, and comprehensive management to reduce the global impact of CKD. Future research efforts should focus on identifying novel therapeutic targets, improving diagnostic techniques, and implementing effective strategies for CKD prevention and management.

The abstract provided here is a general representation and does not include specific details or statistics. The content can vary depending on the scope and focus of the research or article being summarized.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。